Literature DB >> 9932560

Laparoscopic management of adnexal masses in premenopausal and postmenopausal women.

P R Dottino1, D A Levine, D L Ripley, C J Cohen.   

Abstract

OBJECTIVE: To evaluate the feasibility and safety of laparoscopic adnexal mass removal in patients without preselection for benign pathology and assess the operative complications and findings.
METHODS: All patients presenting to the gynecologic oncology service between April 1992 and April 1996 with adnexal masses were candidates for laparoscopic management. Patients underwent preoperative radiological studies and office pelvic examination. Laparoscopic management was attempted on patients without evidence of gross metastatic disease or masses that extended above the umbilicus. Laparotomy was performed if indicated by pathologic findings or technical difficulty. All removed adnexal masses were sent for immediate pathologic diagnosis. The type of procedure, intraoperative findings, and complications were all recorded at the time of procedure.
RESULTS: One hundred sixty patients underwent laparoscopic evaluation for an adnexal mass. Benign pathology was discovered in 139 (87%, 95% confidence interval [CI] 84, 90) patients, and 141 (88%, 95% CI 86, 91) patients were managed laparoscopically. Reasons for laparotomy included technical difficulty, operative complications, or malignancy. Frozen section diagnosis was concordant with the final pathology reports in all but five patients (97% concordance), and no discrepancies resulted in treatment delays.
CONCLUSION: Laparoscopic management of adnexal masses can be successful in a gynecologic oncology population if there is expertise in operative laparoscopy, availability of immediate accurate pathologic examination, and appropriate further treatment where indicated.

Entities:  

Mesh:

Year:  1999        PMID: 9932560     DOI: 10.1016/s0029-7844(98)00425-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Managing adnexal masses: a medical quandary.

Authors:  Surender Mohan; Garima Kapoor; Praveen Kumar Nagpal; Raju Aggarwal; Neha Gami
Journal:  J Clin Diagn Res       Date:  2013-08-17

Review 2.  Role of minimally invasive surgery in staging of ovarian cancer.

Authors:  David A Iglesias; Pedro T Ramirez
Journal:  Curr Treat Options Oncol       Date:  2011-09

Review 3.  Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.

Authors:  Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

4.  Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses.

Authors:  Mohamad S Gad; Nabih I El Khouly; Enrique Soto; Michael Brodman; Linus Chuang; Farr R Nezhat; Herbert F Gretz
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

5.  Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.

Authors:  F D Vogl; M Frey; R Kreienberg; I B Runnebaum
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 6.  Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.

Authors:  Nithya D G Ratnavelu; Andrew P Brown; Susan Mallett; Rob J P M Scholten; Amit Patel; Christina Founta; Khadra Galaal; Paul Cross; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2016-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.